SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in SELLAS Life Sciences Group, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +1 vs. Q1 2022
- Shares held
- 2.98M
- +1.30M (+77.5%) vs. Q1 2022
- Total value
- $6.64M
- −$4.56M (−40.7%) vs. Q1 2022
- New holders
- 8
- 10 more added
- Sold out
- 7
- 3 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 193 | $1.08B |
| Q1 2026 | 160 | $228.4M |
| Q4 2025 | 112 | $133.7M |
| Q3 2025 | 94 | $53.1M |
| Q2 2025 | 79 | $58.7M |
| Q1 2025 | 45 | $15.5M |
| Q4 2024 | 31 | $6.47M |
| Q3 2024 | 33 | $6.77M |
| Q2 2024 | 30 | $4.86M |
| Q1 2024 | 30 | $7.82M |
| Q4 2023 | 31 | $3.74M |
| Q3 2023 | 28 | $4.54M |
| Q2 2023 | 25 | $4.91M |
| Q1 2023 | 22 | $4.28M |
| Q4 2022 | 29 | $4.46M |
| Q3 2022 | 28 | $4.42M |
| Q2 2022 | 26 | $6.64M |
| Q1 2022 | 26 | $11.3M |
| Q4 2021 | 27 | $10.1M |
| Q3 2021 | 30 | $17.1M |
| Q2 2021 | 29 | $21.3M |
| Q1 2021 | 31 | $13.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding SELLAS Life Sciences Group, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 927,984 | $2.07M | 11.20% | +927,984 | New |
| Vanguard Group Inc | 830,119 | $1.85M | 0.00% | +173,200+26.4% | Added |
| BlackRock Inc. | 257,505 | $574.0K | 0.00% | +4,614+1.8% | Added |
| Alyeska Investment Group, L.P. | 254,018 | $566.0K | 0.01% | +254,018 | New |
| Geode Capital Management, LLC | 144,719 | $322.0K | 0.00% | +7,823+5.7% | Added |
| Equitable Holdings, Inc. | 110,000 | $245.0K | 0.00% | +6,000+5.8% | Added |
| Highbridge Capital Management LLC | 100,000 | $223.0K | 0.01% | +100,000 | New |
| Morgan Stanley | 91,471 | $204.0K | 0.00% | +172+0.2% | Added |
| State Street Corp | 51,236 | $114.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 37,639 | $84.0K | 0.00% | +24,269+181.5% | Added |
| Renaissance Technologies LLC | 33,838 | $75.0K | 0.00% | +33,838 | New |
| Northern Trust Corp | 24,605 | $55.0K | 0.00% | −215−0.9% | Reduced |
| Bank of America Corp | 24,268 | $54.0K | 0.00% | +2,612+12.1% | Added |
| Two Sigma Investments, LP | 21,494 | $48.0K | 0.00% | +21,494 | New |
| Bank of New York Mellon Corp | 20,247 | $45.0K | 0.00% | −730−3.5% | Reduced |
| Price T Rowe Associates Inc | 17,100 | $38.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 11,137 | $25.0K | 0.00% | +5,039+82.6% | Added |
| Cubist Systematic Strategies, LLC | 10,100 | $23.0K | 0.00% | +10,100 | New |
| Tower Research Capital LLC (TRC) | 3,755 | $8.00K | 0.00% | +3,291+709.3% | Added |
| JPMorgan Chase & Co | 3,550 | $8.00K | 0.00% | +3,550 | New |
| Cutler Group LP | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,865 | $4.00K | 0.00% | +1,000+115.6% | Added |
| Global Retirement Partners, LLC | 1,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 200 | $0 | 0.00% | −300−60.0% | Reduced |
| Allworth Financial LP | 150 | $0 | 0.00% | 00.0% | Unchanged |
| Parkside Financial Bank & Trust | 2 | $0 | 0.00% | +2 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −101,554−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −96,692−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −31,125−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −22,086−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −15,924−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,912−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1,918−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |